Pacs Group initiated with a Buy at Truist

Truist analyst David MacDonald initiated coverage of Pacs Group with a Buy rating and $32 price target. Pacs is a leading provider of skilled nursing facilities whose decentralized operating model is “a key differentiator,” as it allows for increased operating flexibility and the ability to manage the footprint at the local level backed by scaled resources supported by a robust tech stack, the analyst tells investors.